A novel recombinant multisubunit vaccine against Chlamydia

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3375-3382

  Eko, Francis O ^a   He, Qing ^a   Brown, Teresa ^d   McMillan, Lucinda ^a   Ifere, Godwin O ^a   Ananaba, Godwin A ^c   Lyn, Deborah ^a   Lubitz, Werner ^b   Kellar, Kathryn L ^d   Black, Carolyn M ^d   Igietseme, Joseph U ^a,d  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c CLARK ATLANTA UNIVERSITY   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; DRUG VEHICLE; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIAL GENOME; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLONING VECTOR; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFICACY; GENE; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION CONTROL; LONG TERM CARE; MOLECULAR CLONING; MOUSE; NONHUMAN; OMP GENE; PRIORITY JOURNAL; RECOMBINANT VIBRIO CHOLERAE GHOST; T LYMPHOCYTE; TH1 CELL; VIBRIO CHOLERAE;

EID: 4344636740     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3375     Document Type: Article

References (58)

1. Brunham, R. C., and D. J. Zhang. 1999. Transgene as vaccine for Chlamydia. Am. Heart J. 138:S519.
2. Schachter, J., and J. T. Grayston. 1998. Epidemiology of human chlamydial infections. In Chlamydial Infections. R. S. Stephens, G. I. Byrne, G. Christiansen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgway, P. Saikku, J. Schachter, and W. E. Stamm, eds. Berkeley, San Francisco, p. 3.
3. Stagg, A. J. 1998. Vaccines against Chlamydia: approaches and progress. Mol. Med. Today 4:166.
4. Igietseme, J. U., C. M. Black, and H. D. Caldwell. 2002. Chlamydia vaccines: strategies and status. BioDrugs 16:19.
5. Igietseme, J. U., F. O. Eko, and C. M. Black. 2003. Contemporary approaches to designing and evaluating vaccines against Chlamydia. Expert Rev. Vaccines 2:129.
6. Brunham, R. C., and R. W. Peeling. 1994. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect. Agents Dis. 3:218.
7. Batteiger, B. E., R. G. Rank, P. M. Bavoil, and L. S. F. Soderberg. 1993. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J. Gen. Microbiol. 139:2965.
8. Tuffrey, M., I. Alexander, W. Conlan, C. Woods, and M. Ward. 1992. Hetrotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of C. trachomatis by prior immunization with recombinant serovar L1 major outer membrane protein. Eur. J. Immunol. 23:1169.
9. Su, H., M. Parnell, and H. D. Caldwell. 1995. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection. Vaccine 13:1023.
10. Knight, S. C., S. Iqball, C. Woods, A. Stagg, M. E. Ward, and M. Tuffrey. 1995. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Immunology 85:8.
11. Eko, F., W. Lubitz, L. McMillan, K. Ramey, T. Moore, G. A. Ananaba, D. Lyn, C. M. Black, and J. U. Igietseme. 2003. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine 21:1694.
12. Hatch, T. P., I. Allan, and J. H. Pearce. 1984. Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp. J. Bacteriol. 157:13.
13. Hatch, T. P., M. Miceli, and J. E. Sublett. 1986. Synthesis of disulfide-bonded outer membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J. Bacteriol. 165:379.
14. Newhall, W. J. V. 1987. Biosynthesis and disulifide cross-linking of outer membrane components during the growth cycle of Chlamydia trachomatis. Infect. Immun. 55:162.
15. Everett, K. D. E., M. Dersiderio, and T. P. Hatch. 1994. Characterization of lipoprotein EnvA in Chlamydia psittaci 6BC. J. Bacteriol. 176:6082.
16. Mygind, P., G. Christiansen, and S. Birkelund. 1998. Topological analysis of Chlamydia trachomatis L2 outer membrane protein 2. J. Bacteriol. 180:5784.
17. Allen, J. E., M. C. Cerrone, P. R. Beatty, and R. S. Stephens. 1990. Cysteine-rich outer membrane proteins of Chlamydia trachomatis display compensatory sequence changes between biovariants. Mol. Microbiol. 4:1543.
18. Hanuka, N., M. Glasner, and I. Sarvo. 1988. Detection of IgG and IgA antibodies to Chlamydia trachomatis in sera of patients with chlamydial infections: use of immunoblotting and immunoperoxidase assays. Sex. Transm. Dis. 15:93.
19. Wagar, E. A., J. Schachter, P. Bavoil, and R. S. Stephens. 1990. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J. Infect. Dis. 162:922.
20. Watson, M. W., P. R. Lambden, and I. N. Clarke. 1991. Genetic diversity and identification of human infection by amplification of the chlamydial 60-kilodalton cysteine-rich outer membrane protein gene. J. Clin. Microbiol. 29:1188.
21. Wagels, G., S. Rasmussen, and P. Timms. 1994. Comparison of Chlamydia pneumoniae isolates by Western blot (immunoblot) analysis and DNA sequencing of the OMP2 gene. J. Clin. Microbiol. 32:2820.
22. Watson, M. W., P. R. Lambden, J. S. Everson, and I. N. Clarke. 1994. Immunoreactivity of the 60-kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae expressed in Escherichia coli. Microbiology 140:2003.
23. Mygind, P., G. Christiansen, K. Persson, and S. Birkelund. 1998. Analysis of the humoral immune response to Chlamydia outer membrane protein 2. Clin. Diagn. Lab. Immunol. 5:313.
24. Jones, R. B., and B. E. Batteiger. 1986. Human immune response to Chlamydia trachomatis infections. In Chlamydial Infections. J. Oriel, G. Ridgway, J. Schachter, D. Taylor-Robinson, and M. Ward, eds. Cambridge University Press, London., p. 423.
25. Ward, M. E. 1992. Chlamydial vaccine: future trends. J. Infect. Suppl. 1:11.
26. Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. White, E. K. Hinkey, J. Peterson, T. Utterback, K. Berry, et al. 2000. Genome sequence of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397.
27. Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, et al. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754.
28. Stephens, R. S. 2000. Chlamydial genomics and vaccine antigen discovery. J. Infect. Dis. 181:S521.
29. Longbottom, D., M. Russell, S. M. Dunbar, G. E. Jones, and A. J. Herring. 1998. Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect. Immun. 66:1317.
30. Grimwood, J., L. Olinger, and R. S. Stephens. 2001. Expression of Chlamydia pneumoniae polymorphic membrane protein family genes. Infect. Immun. 69:2383.
31. Niessner, A., C. Kaun, G. Zorn, W. Speidl, Z. Turel, G. Christiansen, A. S. Pedersen, S. Birkelund, S. Simon, A. Georgopoulos, et al. 2003. Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-κB pathway. J. Infect. Dis. 188:108.
32. Kubo, A., and R. S. Stephens. 2000. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Mol. Microbiol. 38:772.
33. Kubo, A., and R. S. Stephens. 2001. Substrate-specific diffusion of select dicarboxylates through Chlamydia trachomatis PorB. Microbiology 147:3135.
34. Kawa, D., and R. Stephens. 2002. Antigenic topology of chlamydial PorB protein and identification of targets for immune neutralization of infectivity. J. Immunol. 168:5184.
35. Ramsey, K. H., L. S. F. Soderberg, and R. G. Rank. 1988. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect. Immun. 56:1320.
36. Stothard, D. R., G. Boguslawski, and R. B. Jones. 1998. Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect. Immun. 66:3618.
37. Kalman, S., W. Mitchell, R. Marathe, C. Lammel, J. Fan, R. W. Hyman, L. Olinger, J. Grimwood, R. W. Davis, and R. S. Stephens. 1999. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21:385.
38. Eko, F. O., U. B. Mayr, S. R. Attridge, and W. Lubitz. 2000. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J. Biotechnol. 83:115.
39. Mermod, N., J. Ramos, P. Lehrbach, and K. Timmis. 1986. Vector for regulated expression of cloned genes in a wide range of Gram-negative bacteria. J. Bacterial. 167:447.
40. Eko, F. O., M. P. Szostak, G. Wanner, and W. Lubitz. 1994. Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development. Vaccine 12:1231.
41. Ramsey, K. H., W. J. Newhall, and R. G. Rank. 1989. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect. Immun. 57:2441.
42. Pal, S., T. J. Fielder, E. M. Peterson, and L. M. de la Maza. 1994. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with a mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 62:3354.
43. Igietseme, J. U., I. M. Uriri, S. N. Kumar, G. A. Ananaba, O. O. Ojior, I. A. Momodu, D. H. Candal, and C. M. Black. 1998. Route of infection that induces a high intensity of γ interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect. Immun. 66:4030.
44. Igietseme, J. U., and R. G. Rank. 1991. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect. Immun. 59:1346.
45. Kees, U., G. Kynast, E. Weber, and P. H. Krammer. 1984. A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocytes (CTL) clones in limiting dilution cultures. J. Immunol. Methods 69:215.
46. Igietseme, J. U., G. A. Ananaba, I. Bolier, S. Bowers, T. Moore, T. Belay, E. O. Eko, D. Lyn, and C. M. Black. 2000. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for enhanced specific Th1 induction: potential for cellular vaccine development. J. Immunol. 164:4212.
47. Black, C., J. Marrazzo, R. Johnson, E. W. Hook, R. Jones, T. Green, J. Schachter, W. Stamm, G. Bolan, M. St. Louis, and D. Martin. 2002. Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J. Clin. Microbiol. 40:3757.
48. Barry, M., and S. Johnston. 1997. Biological features of genetic immunization. Vaccine 15:788.
49. Rank, R. G., and B. E. Batteiger. 1989. Protective role of serum antibody in immunity to chlamydial genital infection. Infect. Immun. 57:299.
50. Pal, S., C. Luke, A. Barbour, E. M. Peterson, and L. M. de la Maza. 2003. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge. Vaccine 21:1455.
51. Igietseme, J. U., F. O. Eko, Q. He, C. Bandea, and C. M. Black. 2004. Developing effective delivery systems for Chlamydia vaccines. Curr. Opin. Mol. Ther. 6:182.
52. Szostak, M. P., A. Hensel, F. O. Eko, R. Klein, T. Auer, H. Mader, A. Haslberger, S. Bunka, G. Wanner, and W. Lubitz. 1996. Bacterial ghosts: non-living candidate vaccines. J. Biotechnol. 44:161.
53. Cotter, T. W., K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen, and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in γ interferon gene knockout mice. Infect. Immun. 65:2145.
54. Perry, L. L., K. Feilzer, and H. D. Caldwell. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and -independent pathways. J. Immunol. 158:3344.
55. Rank, R. G. 1994. Animal models of urogenital infections. Methods Enzymol. 235:83.
56. Su, H., K. Feilzer, H. D. Caldwell, and R. P. Morrison. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65:1993.
57. Moore, T., G. A. Ananaba, J. Bolier, S. Bowers, T. Belay, F. O. Eko, and J. U. Igietseme. 2002. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105:213.
58. Bachmaier, K., N. Neu, L. M. de la Maza, S. Pal, A. Hessel, and J. M. Penninger. 1999. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283:1335.